Ann: Phase I Clinical Trial Dosing Update No 1, page-6

  1. 1,224 Posts.
    lightbulb Created with Sketch. 157
    AGN helps stop further progression of primary brain injury and is a glutamate inhibitor. Main thing AGN has to overcome is that inhibiting Glutamate beyond 30 mins of Brian injury does the opposite in humans for neuronal survival and neurons begin to die without glutamate. AGN half life is 12 hours let’s see what happens. NYR inhibits TRPC channels which are found throughout the brain inhibiting calcium influx in neurons

    AGN Has nothing to do with secondary brain injury and cardiovascular protection. NYR has a larger target market. Different drug
    Last edited by Bendunstan: 09/04/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
22.0¢
Change
-0.025(10.2%)
Mkt cap ! $46.40M
Open High Low Value Volume
24.5¢ 25.0¢ 22.0¢ $256.0K 1.085M

Buyers (Bids)

No. Vol. Price($)
3 67420 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 25083 2
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.